Launch HN: InpharmD (YC W21) – curated drug information for doctors

Re:Launch HN: InpharmD (YC W21) – curated drug information f... by Herodotus38 on Friday January 29, 2021 @01:10PM (#25960377)

Thanks for the link. Anecdotally in our hospital only one patient to my knowledge has survived after a higher dose of dexamethasone (this was only used after the patient was worsening despite the standard 10 days of 6 mg dexamethasone). Whether this helped them or they were going to improve despite can't be known.

I would also be careful about how you use the term atypical, in fact most patients with COVID are typical and improve with the standard treatment. :)

[ Parent | on HN ]

Re:Launch HN: InpharmD (YC W21) – curated drug information f... by aadvani on Friday January 29, 2021 @02:23PM (#25961232)

Great info, and a shame there’s not better real world evidence for cases like this. And I hear you, just making the point that most shouldn't be considered “typical”; we should question everything.

[ Parent | on HN ]